Mold-Tek Packaging Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹198Cr
- +3.7% YoY
- −5.7% QoQ
- Net profit
- ₹14Cr
- 0% YoY
- −6.7% QoQ
- Margin
- 19%
- +1 pp YoY
- 0 pp QoQ
Guidance rank: #86 of 100 in Industrial Products
See the sector's top 10 — free with your mobile number.
The short version
Target to cross INR 1,000 crores in top line next year, implying 13%-14% volume growth. PAT and EBITDA growth are expected to continue around 20% annually for the current and next financial year.
From Mold-Tek Packaging Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Target to cross INR 1,000 crores in top line next year, implying 13%-14% volume growth. (Page 6)
- Aim for 12%-15% volume growth supported by segments showing healthy double-digit growth. (Page 6)
- Food and FMCG segment expected to achieve mid-teen growth with a pick-up from Q4 and summer season. (Page 13)
- Q-Pack segment to continue growing around 25%-30%. (Page 13)
- Pharma segment target of INR 50-55 crores next year, with 30%-35% volume growth anticipated. (Page 6, 13)
- Paint segment expected to grow double-digits driven by Asian Paints and Berger growth. (Page 6, 13)
- Lube segment expected to recover volumes next year after BPCL tender loss, with gains from new client Veedol. (Page 14)
2 more points from Mold-Tek Packaging Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Mold-Tek Packaging Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Current year capex (FY 2025-26) is around INR 120 crores, down from INR 140 crores last year.
- Next year (FY 2026-27) target capex is significantly lower at INR 80-85 crores, as most greenfield projects are completed except some work at Mahad.
- Major expansion planned in Pharma segment next year, with estimated capex of INR 25 crores to develop new products like eye droppers and nasal droppers, with pilot molds already in development.
- Future Pharma growth expected at 30% volume growth post reaching INR 50-55 crores revenue.
2 more points from Mold-Tek Packaging Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Industrial Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Mold-Tek Packaging Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- It mentions a "strong order book" in Pharma as of mid-January, indicating positive demand and expected growth.
- The company's Q4 outlook seems optimistic, with strong momentum and expectations of matching Q1 volume levels.
- New MOUs with clients such as Swiggy and Vibe Generation suggest potential for incremental future orders.
- The management notes increased client confidence due to improved printing capacity and timely deliveries.
Mold-Tek Packaging Ltd — Quarterly revenue & net profit
Mold-Tek Packaging Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 198 | 191 | +3.7% | 210 | -5.7% |
| Operating profit (EBITDA) | 38 | 34 | +11.8% | 39 | -2.6% |
| Operating margin | 19% | 18% | +1 pp | 19% | 0 pp |
| Profit before tax | 19 | 18 | +5.6% | 21 | -9.5% |
| Net profit (PAT) | 14 | 14 | 0% | 15 | -6.7% |
| EPS (₹) | 2.16 | 2.05 | +5.4% | 2.33 | -7.3% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹274 Cr, net profit ₹21 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Mold-Tek Packaging's management said in earlier quarters
Others in Industrial Products this season
- Shri Kanha Stain (Q3 FY26)
Revenue/Sales Figures for the Quarter:** The presentation reports net sales of ₹322.20 crore for Q3 FY 2026. Key investor presentation takeaways from Shri Kanha
- Rappid Valves (Q3 FY26)
Two concrete investments in manufacturing infrastructure totaling ₹139 Crores: . Key investor presentation takeaways from Rappid Valves India Ltd's Q3 FY26 inve
- Prime Cable Industries (Q3 FY26)
Q3 FY26 provisional revenue: INR 71.8 crores . Key investor presentation takeaways from Prime Cable Industries Limited's Q3 FY26 investor presentation — and how
- Shubhshree Biofuels Energy (Q3 FY26)
Revenue in H1 FY26: ₹9,604.6 Lakhs, a 24.1% year-on-year (YoY) increase from ₹7,736.4 Lakhs. Key investor presentation takeaways from Shubhshree Biofuels Energy
Potential multibaggers · Q2 FY27
Potential multibaggers in Industrial Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mold-Tek Packaging Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mold-Tek Packaging Ltd Q3 FY26 results?
Target to cross INR 1,000 crores in top line next year, implying 13%-14% volume growth. PAT and EBITDA growth are expected to continue around 20% annually for the current and next financial year.
What is Mold-Tek Packaging Ltd share price analysis?
Mold-Tek Packaging Ltd currently shows a neutral. The stock trades at a P/E of 30.3 with a market cap of ₹2,307 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mold-Tek Packaging Ltd planning capital expenditure?
Current year capex (FY 2025-26) is around INR 120 crores, down from INR 140 crores last year.
Keep Mold-Tek Packaging Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
